2022-502187-20-00
CTIS ↗
Albutein 50 g/l solución para perfusión.
Subjects with cirrhosis with ACLF-1b, ACLF-2, or ACLF-3a detected either at admission or during hospitalization
pharma · Severe Alpha-1 Antitrypsin Deficiency (AATD)
Grifols
Instituto Grifols S.A.
Grifols trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
ES HQ
1909 Founded
14,121 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- ES
- Founded
- 1909
- Employees
- 14,121
- Programs
- 2
- Drugs
- 2
- Patents
- 0
Grifols clinical trials
Registry index of 2 ClinicalTrials.gov studies linked to Grifols programs — each row shows trial ID, program name, phase, status, and indication.
Grifols trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Grifols.